Adage Capital Partners’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26M | Buy |
1,238,094
+50,000
| +4% | +$1.05M | 0.04% | 379 |
|
|
2025
Q1 | $19.5M | Sell |
1,188,094
-12,000
| -1% | -$197K | 0.04% | 425 |
|
|
2024
Q4 | $30.8M | Buy |
1,200,094
+220,000
| +22% | +$5.65M | 0.05% | 319 |
|
|
2024
Q3 | $31M | Sell |
980,094
-1,085,000
| -53% | -$34.4M | 0.05% | 329 |
|
|
2024
Q2 | $72.5M | Sell |
2,065,094
-402,013
| -16% | -$14.1M | 0.13% | 157 |
|
|
2024
Q1 | $108M | Sell |
2,467,107
-457,987
| -16% | -$20.1M | 0.2% | 100 |
|
|
2023
Q4 | $104M | Buy |
2,925,094
+638,133
| +28% | +$22.7M | 0.22% | 106 |
|
|
2023
Q3 | $61.7M | Sell |
2,286,961
-288,149
| -11% | -$7.77M | 0.14% | 165 |
|
|
2023
Q2 | $60.5M | Sell |
2,575,110
-101,449
| -4% | -$2.38M | 0.13% | 172 |
|
|
2023
Q1 | $36.7M | Buy |
2,676,559
+475,000
| +22% | +$6.52M | 0.08% | 280 |
|
|
2022
Q4 | $40M | Buy |
2,201,559
+351,465
| +19% | +$6.39M | 0.1% | 245 |
|
|
2022
Q3 | $27.6M | Buy |
1,850,094
+1,745,693
| +1,672% | +$26M | 0.07% | 321 |
|
|
2022
Q2 | $1.44M | Sell |
104,401
-88,900
| -46% | -$1.23M | ﹤0.01% | 900 |
|
|
2022
Q1 | $2.16M | Sell |
193,301
-50,042
| -21% | -$560K | ﹤0.01% | 895 |
|
|
2021
Q4 | $5.75M | Sell |
243,343
-6,657
| -3% | -$157K | 0.01% | 801 |
|
|
2021
Q3 | $6.37M | Sell |
250,000
-157,899
| -39% | -$4.03M | 0.01% | 800 |
|
|
2021
Q2 | $8.56M | Sell |
407,899
-100,000
| -20% | -$2.1M | 0.02% | 734 |
|
|
2021
Q1 | $11.9M | Buy |
+507,899
| New | +$11.9M | 0.02% | 620 |
|